<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jekhmane S</submitter><funding>Netherlands Centre for One Health</funding><funding>Dutch Research Council (NWO)</funding><funding>EC | Horizon 2020 Framework Programme</funding><funding>EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)</funding><pagination>1778-1791</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11222147</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(7)</volume><pubmed_abstract>Antimicrobial resistance is a leading cause of mortality, calling for the development of new antibiotics. The fungal antibiotic plectasin is a eukaryotic host defence peptide that blocks bacterial cell wall synthesis. Here, using a combination of solid-state nuclear magnetic resonance, atomic force microscopy and activity assays, we show that plectasin uses a calcium-sensitive supramolecular killing mechanism. Efficient and selective binding of the target lipid II, a cell wall precursor with an irreplaceable pyrophosphate, is achieved by the oligomerization of plectasin into dense supra-structures that only form on bacterial membranes that comprise lipid II. Oligomerization and target binding of plectasin are interdependent and are enhanced by the coordination of calcium ions to plectasin'</pubmed_abstract><journal>Nature microbiology</journal><pubmed_title>Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism.</pubmed_title><pmcid>PMC11222147</pmcid><funding_grant_id>711.018.001</funding_grant_id><funding_grant_id>101045485</funding_grant_id><funding_grant_id>184.035.002</funding_grant_id><funding_grant_id>184.032.207</funding_grant_id><funding_grant_id>101008500</funding_grant_id><funding_grant_id>723.014.003</funding_grant_id><pubmed_authors>Slingerland CJ</pubmed_authors><pubmed_authors>Kunzler M</pubmed_authors><pubmed_authors>Lelli M</pubmed_authors><pubmed_authors>Matheson EJ</pubmed_authors><pubmed_authors>Cochrane RVK</pubmed_authors><pubmed_authors>Lorent JH</pubmed_authors><pubmed_authors>Medeiros-Silva J</pubmed_authors><pubmed_authors>Cochrane SA</pubmed_authors><pubmed_authors>Jekhmane S</pubmed_authors><pubmed_authors>Charitou V</pubmed_authors><pubmed_authors>Lavore F</pubmed_authors><pubmed_authors>Consoli NA</pubmed_authors><pubmed_authors>Derks MGN</pubmed_authors><pubmed_authors>Maity S</pubmed_authors><pubmed_authors>Roos WH</pubmed_authors><pubmed_authors>Breukink E</pubmed_authors><pubmed_authors>Baldus M</pubmed_authors><pubmed_authors>Weingarth M</pubmed_authors><pubmed_authors>Fetz C</pubmed_authors><pubmed_authors>Tehrani KHME</pubmed_authors><pubmed_authors>Ammerlaan D</pubmed_authors><pubmed_authors>van der Weijde M</pubmed_authors><pubmed_authors>Elenbaas BOW</pubmed_authors><pubmed_authors>Cox R</pubmed_authors><pubmed_authors>Martin NI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Host defence peptide plectasin targets bacterial cell wall precursor lipid II by a calcium-sensitive supramolecular mechanism.</name><description>Antimicrobial resistance is a leading cause of mortality, calling for the development of new antibiotics. The fungal antibiotic plectasin is a eukaryotic host defence peptide that blocks bacterial cell wall synthesis. Here, using a combination of solid-state nuclear magnetic resonance, atomic force microscopy and activity assays, we show that plectasin uses a calcium-sensitive supramolecular killing mechanism. Efficient and selective binding of the target lipid II, a cell wall precursor with an irreplaceable pyrophosphate, is achieved by the oligomerization of plectasin into dense supra-structures that only form on bacterial membranes that comprise lipid II. Oligomerization and target binding of plectasin are interdependent and are enhanced by the coordination of calcium ions to plectasin'</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-04T12:55:23.731Z</modification><creation>2025-04-04T12:55:23.731Z</creation></dates><accession>S-EPMC11222147</accession><cross_references><pubmed>38783023</pubmed><doi>10.1038/s41564-024-01696-9</doi></cross_references></HashMap>